U.S. FDA Accepts and Grants Priority Review for Eisai’s Biologics License Application of Lecanemab 17 jam ago
Register for the Course! 5th Edition of Global CX Summit India Physical Conference on July 7 2 hari ago
Regina Miracle Fiscal 2022 Results Hit Record High, Revenue Increased by 39.7% to HK$8.35 Billion, Adjusted Net Profit More than Doubled to HK$582 Million 1 minggu ago
SEAPRWire Releases Branding-Insight Program, Empowering Communicators to Further Understand Audiences 1 minggu ago
Eisai Publishes Potential Economic Value of Investigational Lecanemab in Peer-Reviewed Neurology and Therapy Journal 2 minggu ago
The Mechanism of Action of SinoMab’s Flagship Product SM03 is Successfully Published in the Journal of Immunology, a Reputable Journal on Immunology in the U.S. 2 minggu ago
The 5th Brasil Investment Forum Brought Together Global Business Leaders, Actively Promotes the High-quality Investment Opportunities in Brazil 2 minggu ago
Mitsubishi Power Signs Decarbonization Agreement for Hydrogen Fuel Conversion with Leading Egyptian O&G Refinery ANRPC 3 minggu ago
Splyt and Binance Enter into a Partnership to Offer Ridehailing Services and Experiences on Binance Marketplace 3 minggu ago
Nojima Partners with GlobalLogic, a Hitachi Group Company, to Accelerate Its Digital Transformation 4 minggu ago
NTT DOCOMO and NTT to Collaborate on 6G Experimental Trials with World-leading Mobile Technology Vendors 1 bulan ago
Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting 1 bulan ago
